Labcorp Holdings Inc. is a key player in the life sciences industry, offering a wide range of laboratory services worldwide. With a market capitalization of $22.94 billion, it conducts hundreds of millions of tests annually. Labcorp’s stock has outperformed the S&P 500 and the Health Care Select Sector SPDR Fund. In the second quarter of fiscal 2025, Labcorp reported a revenue increase of 9.5% YOY to $3.53 billion, surpassing analyst expectations. Wall Street analysts project a strong EPS growth for the company, with a consensus “Strong Buy” rating. Following Q2 results, analysts have maintained positive outlooks, with price targets indicating potential upside.

Read more at Yahoo Finance: Do Wall Street Analysts Like Labcorp Holdings Stock?